Merck’s Winrevair: Pulmonary arterial hypertension drug shows success ahead of schedule
Strong positive interim data from an earlier Phase 3 trial has led to early cessation of Merck’s pulmonary arterial hypertension ...
Tag: cardiovascular disease
Novo Nordisk’s Rybelsus demonstrates reduction in cardiovascular events for patients with Type 2 diabetes and cardiovascular disease
Rybelsus in combination with standard T2DM therapy reduced the risk of major cardiovascular events by 14% in patients with diabetes ...
High cardiovascular disease mortality among Native Hawaiian and Pacific Islander adults
1. In this cross-sectional study, researchers found that Native Hawaiian and Pacific Islander (NHPI) adults aged 35 years or older ...
#VisualAbstract Edoxaban Monotherapy has Lower Risks for Atrial Fibrillation and Stable Coronary Artery Disease than Dual Antithrombotics
Click here to read this study in NEJM. ©2024 2 Minute Medicine, Inc. All rights reserved. No works may be reproduced without ...
Early intensive glycemic control reduces long-term risk of death and myocardial infarction in patients with type 2 diabetes
1. Sulfonylurea, insulin therapy, and metformin resulted in a significant relative risk reduction for all-cause mortality and myocardial infarction. 2. ...
Improved adherence but worsening disparities in follow-up after cardiovascular hospitalizations
1. In this retrospective cohort study, it was found that timely follow-up after hospitalization for acute myocardial infarction and heart ...
The Scan by 2 Minute Medicine®: Inside the Mind: Noland’s Journey with Neuralink, Lung Cancer Puzzle: Female Asian Never-Smokers, Living Longer with the Mediterranean Diet, Health Perks of Regular Sleep and Meals
The Scan by 2 Minute Medicine® is a pop-culture medical newsletter and exclusive benefit for 2 Minute Medicine Plus subscribers. ...
#VisualAbstract: Apolipoprotein A1 Infusions do not Improve Cardiovascular Outcomes after Acute Myocardial Infarction
Click here to read this study in NEJM. ©2024 2 Minute Medicine, Inc. All rights reserved. No works may be ...
Non-alcoholic fatty liver disease increases cardiovascular and mortality risk in patients with diabetes
1. The risk of cardiovascular disease (CVD) and all-cause death for individuals with type 2 diabetes mellitus (T2DM) is increased ...
Probiotic supplementation may improve outcomes in patients with type 2 diabetes
1. Patients with type 2 diabetes randomized to using probiotic supplements were found to have significantly reduced lipoprotein-associated phospholipase A2 ...